PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
TeaTime deliver fresh and healthy tea blends straight to your door. Simply choose how often you wish to receive your box, weekly or fortnightly and TeaTime will dispatch a selection of 4 of their blends out to you within 48 hours.
days to go:
Expired
investment:
£18,940
Cellar Rats, led by Founder and CEO Matt, aims to disrupt the wine industry by changing the way people discover, buy, and enjoy wine. With a background in successfully transforming consumer brands, they're determined to revolutionize the UK's £17 billion wine market, which currently faces challenges due to a lack of consumer wine knowledge. Starting with a subscription service and extending to shake up traditional wine retail, Cellar Rats is poised to reshape the wine industry from the ground up.
days to go:
Expired
investment:
£282,164
Mums Bake Cakes allows anyone anywhere that is looking to send a gift can now source a homemade cake to be hand delivered by any of our bakers across the UK. Mums Bake Cakes encourages bakers to turn their passion into a business.
days to go:
Expired
investment:
£2,440
The company operates within the Fast Moving Consumer Goods market and will be launching KOKONATA drink product.KOKONATA coconut water is a particular variety of coconut that is indigenous to the tropical island of Sri Lanka called “King Coconut” this is a particular type of Yellow Coconut which is only grown in this region. On the Island, Kokonata coconut trees grow freely and in abundance with little or no human intervention. Its taste and ability to replenish the body make it the premium source of hydration, hence the name “King” of all coconuts.You need to be registered as an investor to see thisJoin Now
days to go:
Expired
investment:
Withheld
H2O-ganics is using brand new technology to transform UK crop-growing. They are able to use this technology to grow vegetables indoors, without the need for pesticides and protected from disease and environmental factors.
days to go:
Expired
investment:
£76,418
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
Stroodles are straws made from pasta, which eliminates the use of plastic and wet paper straws. It lasts over 1 hour, is tasteless, 100% biodegradable and edible. The company has received worldwide brand exposure through viral content via Unilad and BBC. It has B2B and B2C clients including Marriott and Ibis in Europe, and it has stockists in the UK and Austria. The company will use the funds to scale marketing and sales and to become the market leader in the straw market.
days to go:
Expired
investment:
£214,980
